KR101379664B1 - 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물 - Google Patents

리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물 Download PDF

Info

Publication number
KR101379664B1
KR101379664B1 KR1020080093344A KR20080093344A KR101379664B1 KR 101379664 B1 KR101379664 B1 KR 101379664B1 KR 1020080093344 A KR1020080093344 A KR 1020080093344A KR 20080093344 A KR20080093344 A KR 20080093344A KR 101379664 B1 KR101379664 B1 KR 101379664B1
Authority
KR
South Korea
Prior art keywords
minutes
vitamin
salt
risedronic acid
solution
Prior art date
Application number
KR1020080093344A
Other languages
English (en)
Korean (ko)
Other versions
KR20100034294A (ko
Inventor
김진선
이근혁
류종현
김재신
Original Assignee
한림제약(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42060257&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101379664(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 한림제약(주) filed Critical 한림제약(주)
Priority to KR1020080093344A priority Critical patent/KR101379664B1/ko
Priority to PCT/KR2009/005391 priority patent/WO2010036005A2/fr
Priority to CN2009801355431A priority patent/CN102149387A/zh
Publication of KR20100034294A publication Critical patent/KR20100034294A/ko
Application granted granted Critical
Publication of KR101379664B1 publication Critical patent/KR101379664B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020080093344A 2008-09-23 2008-09-23 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물 KR101379664B1 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020080093344A KR101379664B1 (ko) 2008-09-23 2008-09-23 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물
PCT/KR2009/005391 WO2010036005A2 (fr) 2008-09-23 2009-09-22 Composition pharmaceutique comprenant de l'acide risédronique ou un sel de celui-ci et de la vitamine d
CN2009801355431A CN102149387A (zh) 2008-09-23 2009-09-22 含利塞膦酸或其盐和维生素d的药物组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080093344A KR101379664B1 (ko) 2008-09-23 2008-09-23 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020130017396A Division KR20130031313A (ko) 2013-02-19 2013-02-19 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물

Publications (2)

Publication Number Publication Date
KR20100034294A KR20100034294A (ko) 2010-04-01
KR101379664B1 true KR101379664B1 (ko) 2014-04-02

Family

ID=42060257

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080093344A KR101379664B1 (ko) 2008-09-23 2008-09-23 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물

Country Status (3)

Country Link
KR (1) KR101379664B1 (fr)
CN (1) CN102149387A (fr)
WO (1) WO2010036005A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160144663A (ko) 2015-06-09 2016-12-19 최숙 제제 및 이의 제조방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070065507A1 (en) * 2005-09-16 2007-03-22 Selamine Limited Bisphosphonate formulation
KR100844256B1 (ko) * 2007-03-23 2008-07-07 코오롱제약주식회사 리세드로네이트와 비타민 ｄ를 포함하는 대사성 골질환치료용 약제조성물 및 이의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050070504A1 (en) * 2001-12-21 2005-03-31 The Procter & Gamble Co. Risedronate compositions and their methods of use
KR100822133B1 (ko) * 2006-11-06 2008-04-15 한미약품 주식회사 비타민 ｄ 또는 이의 유도체의 고체분산체 및비스포스포네이트를 포함하는, 골다공증 예방 또는 치료용복합제제

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070065507A1 (en) * 2005-09-16 2007-03-22 Selamine Limited Bisphosphonate formulation
KR100844256B1 (ko) * 2007-03-23 2008-07-07 코오롱제약주식회사 리세드로네이트와 비타민 ｄ를 포함하는 대사성 골질환치료용 약제조성물 및 이의 제조방법

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160144663A (ko) 2015-06-09 2016-12-19 최숙 제제 및 이의 제조방법

Also Published As

Publication number Publication date
WO2010036005A2 (fr) 2010-04-01
CN102149387A (zh) 2011-08-10
KR20100034294A (ko) 2010-04-01
WO2010036005A3 (fr) 2010-07-15

Similar Documents

Publication Publication Date Title
ES2908655T3 (es) Composiciones farmacéuticas sólidas y procedimientos para su producción
EP2231121B1 (fr) Compositions pharmaceutiques
JP2023026623A (ja) エソメプラゾール及び炭酸水素ナトリウムを含む、優れた溶解特性を備えた薬学的製剤
RU2533230C2 (ru) Фармацевтические композиции, содержащие производные бисфосфоната и высокие дозы холекальциферола
KR20120005228A (ko) 골다공증 치료용 비스포스폰산 함유 장용 약학조성물 및 그의 제조방법
WO2021086292A1 (fr) Formulations de comprimés bicouches comprenant de la dapagliflozine et de la metformine
KR20100089532A (ko) 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
KR20140041641A (ko) 이토프라이드 염산염을 함유하는 제어 방출성 경구 제제의 조성물 및 그의 제조방법
KR102612983B1 (ko) 용출율이 향상된 라록시펜, 및 비타민 d 또는 그 유도체를 포함하는 복합 캡슐제 및 이의 제조방법
KR20190037182A (ko) 에스오메프라졸 및 그의 약학적으로 허용가능한 염을 함유하는 다중 투여 단위 정제를 포함한 약제학적 조성물 및 그의 제조 방법
KR101379664B1 (ko) 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물
JP6374879B2 (ja) 骨粗しょう症治療用の安定な医薬組成物
KR101739731B1 (ko) 유당불내성 환자에게 투여가 가능하며, 복용편의성이 향상된 게피티니브를 함유하는 약제학적 조성물
EP4192439A1 (fr) Formes posologiques solides de palbociclib
KR102389339B1 (ko) 방출 제어되는 고함량 탐스로신 정제 조성물 및 이의 제조방법
KR20130031313A (ko) 리세드론산 또는 그의 염 및 비타민 ｄ를 포함하는 약학 조성물
KR20210012919A (ko) 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
KR102351931B1 (ko) 라록시펜 염산염을 포함하는 약학 조성물
KR20200074759A (ko) 두타스테라이드를 함유하는 고형제제
KR102136459B1 (ko) 바제독시펜과 비타민 d를 포함하는 복합제제
KR102146724B1 (ko) 벤즈이미다졸계 화합물을 포함하는 약제학적 조성물 및 이의 제조방법
CN114762687A (zh) 一种钾离子竞争性酸阻滞剂的预混物及其制备
KR20230124504A (ko) 라베프라졸 및 탄산수소나트륨을 포함하는 약학적 조성물
WO2013100876A1 (fr) Formulations de rispéridone
AU2022269659A1 (en) Erodible tablet

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
A107 Divisional application of patent
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
J206 Request for trial to confirm the scope of a patent right
J204 Request for invalidation trial [patent]
J206 Request for trial to confirm the scope of a patent right
J204 Request for invalidation trial [patent]
J206 Request for trial to confirm the scope of a patent right
J501 Disposition of invalidation of trial
J501 Disposition of invalidation of trial
J121 Written withdrawal of request for trial
J121 Written withdrawal of request for trial
J121 Written withdrawal of request for trial
J121 Written withdrawal of request for trial
J301 Trial decision

Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20150501

Effective date: 20160120

Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20150430

Effective date: 20160120

Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20150417

Effective date: 20160120

J121 Written withdrawal of request for trial
J121 Written withdrawal of request for trial
J121 Written withdrawal of request for trial
J121 Written withdrawal of request for trial
FPAY Annual fee payment

Payment date: 20200210

Year of fee payment: 7